Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Daniel Muldoon

9PUBLICATIONS
135CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer geneticsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|Mar 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.

Wungki Park, Catherine A O'Connor, Joanne F Chou

|Mar 25, 2026
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.

Maria M Rubinstein, Jennifer Y Ge, Qin Zhou

|Jan 28, 2026
Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer.

Manu Prasad, Alex T Cheng, Marcel Mayer

|Sep 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial.

Wungki Park, Catherine O'Connor, Joanne Chou

|Jun 02, 2025
Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic dissemination.

Karena Zhao, Joris Vos, Stanley Lam

|Jan 03, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival.

Anna M Varghese, Maria A Perry, Joanne F Chou

Pageof 2

Frequent Collaborators

8 joint publications

Chaitanya Bandlamudi

5 joint publications

Michael F Berger

3 joint publications

Nadeem Riaz

3 joint publications

Maria Perry

3 joint publications

Mark Ta Donoghue

3 joint publications

Olca Basturk

3 joint publications

Wungki Park

3 joint publications

Anna Varghese

3 joint publications

Alice Wei

3 joint publications

Fiyinfolu Balogun

Frequent Collaborators

8 joint publications

Chaitanya Bandlamudi

5 joint publications

Michael F Berger

3 joint publications

Nadeem Riaz

3 joint publications

Maria Perry

Top Related Videos

Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay
10:43

Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay

Published on : Oct 11, 2017

40.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

8.1K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on : Jun 14, 2019

11.2K
See more related videos

Top Related Videos

Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay
10:43

Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay

Published on : Oct 11, 2017

40.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

8.1K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on : Jun 14, 2019

11.2K
See more related videos